CAR T-cell therapy treatments
Our physicians and medical teams will explore whether CAR T-cell therapy is right for you and your unique treatment plan.
How CAR T-cell therapy works
We always want you to feel informed about your health. The CAR T-cell therapy process involves the following steps:
- White blood cells are collected through a procedure called apheresis.
- The T-cells are isolated from other blood cells.
- The T-cells are then modified to become “fighter” T-cells which recognize and target the cancer cells.
- The new “fighter” T-cells are reinfused into your body to allow tumor cell recognition.
Our CAR T-cell therapy program
CAR T-cell therapy, an exciting new treatment, has been tested in research trials for the past few years. This cell therapy will be introduced gradually, and is available only at centers where doctors and nurses are specially-trained and meet the Foundation for Accreditation of Cellular Therapy (FACT) accreditation standards.
The Sarah Cannon Blood Cancer Center is proud to offer FDA-approved CAR T-cell therapy. Our comprehensive care team is specially trained in this therapy and can now administer it for adult diffuse large B-cell lymphoma. CAR T-cell therapy will be available for other cancers in the future.
To learn more about our clinical trial options, please call (512) 816-5644.
About HCA Healthcare Sarah Cannon Cancer Network
Fighting cancer takes a team
HCA Healthcare Sarah Cannon Cancer Network delivers you exceptional cancer care through cutting-edge, specialized treatments, multidisciplinary collaboration and care that is tailored to you. Our teams of passionate caregivers and global oncology experts across the United States and United Kingdom offer services and expertise that extend across many types of cancer. Together with the full support of HCA Healthcare – a leading provider of cancer care and research – we’re with you and your family from diagnosis through survivorship.